Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 372.30
-5.30 (-1.40%)
Jun 30, 2026, 4:59 PM CET
Revenue
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 | Sep '13 Sep 30, 2013 |
Ostomy Care Revenue | 9.97B | 9.90B | 9.55B | |||||||||||
Ostomy Care Revenue Growth | 0.73% | 3.69% | 5.77% | |||||||||||
Continence Care Revenue | 9.13B | 8.98B | 8.54B | |||||||||||
Continence Care Revenue Growth | 1.66% | 5.20% | 7.31% | |||||||||||
Chronic Care Revenue | 19.10B | 18.88B | 18.09B | |||||||||||
Chronic Care Revenue Growth | 1.17% | 4.40% | 6.49% | |||||||||||
Voice and Respiratory Care Revenue | 2.34B | 2.28B | 2.11B | |||||||||||
Voice and Respiratory Care Revenue Growth | 2.41% | 8.06% | 8.82% | |||||||||||
Interventional Urology Revenue | 2.82B | 2.78B | 2.78B | |||||||||||
Interventional Urology Revenue Growth | 1.26% | 0.32% | 3.78% | |||||||||||
Advanced Wound Dressings Revenue | 2.56B | 2.68B | 3.03B | |||||||||||
Advanced Wound Dressings Revenue Growth | -4.30% | -11.83% | 7.21% | |||||||||||
Biologics Revenue | 1.23B | 1.25B | 1.03B | |||||||||||
Biologics Revenue Growth | -1.99% | 22.22% | 1268.00% | |||||||||||
Advanced Wound Care Revenue | 3.79B | 3.93B | 4.06B | |||||||||||
Advanced Wound Care Revenue Growth | -3.56% | -3.23% | 39.76% | |||||||||||
Revenue (Total) | 28.05B | 27.87B | 27.03B | |||||||||||
Revenue (Total) Growth | 0.61% | 3.12% | 10.33% |
Revenue by Geography
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 | Sep '13 Sep 30, 2013 |
European Markets Revenue | 15.87B | 15.51B | 14.75B | |||||||||||
European Markets Revenue Growth | 2.31% | 5.15% | 6.05% | |||||||||||
Other Developed Markets Revenue | 7.65B | 7.83B | 7.75B | |||||||||||
Other Developed Markets Revenue Growth | -2.26% | 1.06% | 19.54% | |||||||||||
Emerging Markets Revenue | 4.53B | 4.54B | 4.53B | |||||||||||
Emerging Markets Revenue Growth | -0.22% | 0.04% | 10.26% | |||||||||||
Revenue (Total) | 28.05B | 27.87B | 27.03B | |||||||||||
Revenue (Total) Growth | 0.61% | 3.12% | 10.33% |
EBIT
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 | Sep '13 Sep 30, 2013 |
Chronic Care Segment EBIT | 11.25B | 11.06B | 10.44B | |||||||||||
Chronic Care Segment EBIT Growth | 1.65% | 5.96% | 6.44% | |||||||||||
Voice and Respiratory Care Segment EBIT | 837.00M | 837.00M | 736.00M | |||||||||||
Voice and Respiratory Care Segment EBIT Growth | - | 13.72% | 10.51% | |||||||||||
Interventional Urology Segment EBIT | 1.01B | 984.00M | 976.00M | |||||||||||
Interventional Urology Segment EBIT Growth | 2.54% | 0.82% | 3.06% | |||||||||||
Advanced Wound Dressings Segment EBIT | 1.05B | 1.11B | 1.15B | |||||||||||
Advanced Wound Dressings Segment EBIT Growth | -5.16% | -4.16% | 7.86% | |||||||||||
Biologics Segment EBIT | 89.00M | 159.00M | 101.00M | |||||||||||
Biologics Segment EBIT Growth | -44.02% | 57.43% | 1022.22% | |||||||||||
Advanced Wound Care Segment EBIT | 1.14B | 1.26B | 1.25B | |||||||||||
Advanced Wound Care Segment EBIT Growth | -10.05% | 0.80% | 16.33% | |||||||||||
Operating Income (Total) | 4.17B | 7.20B | 7.32B | |||||||||||
Operating Income (Total) Growth | -42.15% | -1.63% | 8.11% |
Key Performance Indicators
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | Sep '14 Sep 30, 2014 | Sep '13 Sep 30, 2013 |
Ostomy Care Organic Growth | 6.00% | 7.00% | |||||||||||
Continence Care Organic Growth | 8.00% | 8.00% | |||||||||||
Voice and Respiratory Care Organic Growth | 9.00% | 11.00% | |||||||||||
Advanced Wound Care Organic Growth | 8.00% | 10.00% | |||||||||||
Interventional Urology Organic Growth | 2.00% | 5.00% | |||||||||||
Total Organic Growth | 7.00% | 8.00% |